Serveur d'exploration sur le thulium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000278 ( Pmc/Corpus ); précédent : 0002779; suivant : 0002790 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Vaporization of the Prostate with 150-W Thulium Laser: Complications with 6-Month Follow-Up</title>
<author>
<name sortKey="Vargas, Cesar" sort="Vargas, Cesar" uniqKey="Vargas C" first="César" last="Vargas">César Vargas</name>
</author>
<author>
<name sortKey="Garcia Larrosa, Alejandro" sort="Garcia Larrosa, Alejandro" uniqKey="Garcia Larrosa A" first="Alejandro" last="García-Larrosa">Alejandro García-Larrosa</name>
</author>
<author>
<name sortKey="Capdevila, Santiago" sort="Capdevila, Santiago" uniqKey="Capdevila S" first="Santiago" last="Capdevila">Santiago Capdevila</name>
</author>
<author>
<name sortKey="Laborda, Ainhoa" sort="Laborda, Ainhoa" uniqKey="Laborda A" first="Ainhoa" last="Laborda">Ainhoa Laborda</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24521152</idno>
<idno type="pmc">4074741</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074741</idno>
<idno type="RBID">PMC:4074741</idno>
<idno type="doi">10.1089/end.2013.0715</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000278</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000278</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Vaporization of the Prostate with 150-W Thulium Laser: Complications with 6-Month Follow-Up</title>
<author>
<name sortKey="Vargas, Cesar" sort="Vargas, Cesar" uniqKey="Vargas C" first="César" last="Vargas">César Vargas</name>
</author>
<author>
<name sortKey="Garcia Larrosa, Alejandro" sort="Garcia Larrosa, Alejandro" uniqKey="Garcia Larrosa A" first="Alejandro" last="García-Larrosa">Alejandro García-Larrosa</name>
</author>
<author>
<name sortKey="Capdevila, Santiago" sort="Capdevila, Santiago" uniqKey="Capdevila S" first="Santiago" last="Capdevila">Santiago Capdevila</name>
</author>
<author>
<name sortKey="Laborda, Ainhoa" sort="Laborda, Ainhoa" uniqKey="Laborda A" first="Ainhoa" last="Laborda">Ainhoa Laborda</name>
</author>
</analytic>
<series>
<title level="j">Journal of Endourology</title>
<idno type="ISSN">0892-7790</idno>
<idno type="eISSN">1557-900X</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>
<bold>
<italic>Purpose:</italic>
</bold>
To analyze the efficacy and safety of vaporization of the prostate (VP) with the 150-W thulium:yttrium-aluminum-garnet (Tm:YAG) laser.</p>
<p>
<bold>
<italic>Patients and Methods:</italic>
</bold>
In a prospective series of 55 patients with small- and medium-size prostates undergoing major outpatient surgery (MOS), the primary objectives were to analyze changes in maximum flow (Q
<sub>max</sub>
) and International Prostate Symptom Score (IPSS) after 6 months. Immediate (<30 days) and late (>30 days) complications were subsequently recorded.</p>
<p>
<bold>
<italic>Results:</italic>
</bold>
An increase in mean Q
<sub>max</sub>
of 9.33 mL/s (95% confidence interval [CI] of the mean difference 6.73–11.93;
<italic>P</italic>
<0.001) was recorded, and mean IPSS was reduced by 16.88 points (95% CI 14.22–19.54;
<italic>P</italic>
<0.001). The immediate complications recorded were acute urinary retention (one patient), urinary tract infection without fever (two patients), and macroscopic hematuria (two patients). The only late complication observed was bladder neck sclerosis (one patient).</p>
<p>
<bold>
<italic>Conclusion:</italic>
</bold>
After 6 months, VP with 150-W Tm:YAG presents promising results in the clinical improvement of patients with small- and medium-size prostates. Its complication rate is low and it offers excellent hemostasis. The data from our study provide the basis for the design of clinical trials to compare this technique with other procedures.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Endourol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Endourol</journal-id>
<journal-id journal-id-type="publisher-id">end</journal-id>
<journal-title-group>
<journal-title>Journal of Endourology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0892-7790</issn>
<issn pub-type="epub">1557-900X</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc.</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24521152</article-id>
<article-id pub-id-type="pmc">4074741</article-id>
<article-id pub-id-type="publisher-id">10.1089/end.2013.0715</article-id>
<article-id pub-id-type="doi">10.1089/end.2013.0715</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Transurethral and Lower Tract Procedures</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Vaporization of the Prostate with 150-W Thulium Laser: Complications with 6-Month Follow-Up</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vargas</surname>
<given-names>César</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Larrosa</surname>
<given-names>Alejandro</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capdevila</surname>
<given-names>Santiago</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laborda</surname>
<given-names>Ainhoa</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<aff id="aff1">Department of Urology,
<institution>Hospital de Viladecans</institution>
, Viladecans, Barcelona,
<country>Spain</country>
.</aff>
</contrib-group>
<author-notes>
<corresp>
<addr-line>Address correspondence to:</addr-line>
<addr-line>
<italic>César Vargas, MD</italic>
</addr-line>
<addr-line>
<italic>Department of Urology</italic>
</addr-line>
<institution>
<italic>Hospital de Viladecans</italic>
</institution>
<addr-line>
<italic>Avinguda de Gavà, 38</italic>
</addr-line>
<addr-line>
<italic>08840 Viladecans, Barcelona</italic>
</addr-line>
<country>Spain</country>
<break></break>
<italic>E-mail:</italic>
<email xlink:href="mailto:urocvb@gmail.com">urocvb@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>7</month>
<year>2014</year>
<pmc-comment>string-date: July 2014</pmc-comment>
</pub-date>
<volume>28</volume>
<issue>7</issue>
<fpage>841</fpage>
<lpage>845</lpage>
<permissions>
<copyright-statement>Copyright 2014, Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2014</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:type="simple" xlink:href="end.2013.0715.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>
<bold>
<italic>Purpose:</italic>
</bold>
To analyze the efficacy and safety of vaporization of the prostate (VP) with the 150-W thulium:yttrium-aluminum-garnet (Tm:YAG) laser.</p>
<p>
<bold>
<italic>Patients and Methods:</italic>
</bold>
In a prospective series of 55 patients with small- and medium-size prostates undergoing major outpatient surgery (MOS), the primary objectives were to analyze changes in maximum flow (Q
<sub>max</sub>
) and International Prostate Symptom Score (IPSS) after 6 months. Immediate (<30 days) and late (>30 days) complications were subsequently recorded.</p>
<p>
<bold>
<italic>Results:</italic>
</bold>
An increase in mean Q
<sub>max</sub>
of 9.33 mL/s (95% confidence interval [CI] of the mean difference 6.73–11.93;
<italic>P</italic>
<0.001) was recorded, and mean IPSS was reduced by 16.88 points (95% CI 14.22–19.54;
<italic>P</italic>
<0.001). The immediate complications recorded were acute urinary retention (one patient), urinary tract infection without fever (two patients), and macroscopic hematuria (two patients). The only late complication observed was bladder neck sclerosis (one patient).</p>
<p>
<bold>
<italic>Conclusion:</italic>
</bold>
After 6 months, VP with 150-W Tm:YAG presents promising results in the clinical improvement of patients with small- and medium-size prostates. Its complication rate is low and it offers excellent hemostasis. The data from our study provide the basis for the design of clinical trials to compare this technique with other procedures.</p>
</abstract>
<counts>
<table-count count="5"></table-count>
<ref-count count="22"></ref-count>
<page-count count="5"></page-count>
</counts>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000278  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000278  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    ThuliumV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu May 12 08:27:09 2016. Site generation: Thu Mar 7 22:33:44 2024